Literature DB >> 22805536

Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles.

A La Marca1, E Papaleo, V Grisendi, C Argento, S Giulini, A Volpe.   

Abstract

OBJECTIVE: To elaborate a nomogram based on markers of ovarian reserve for the calculation of the appropriate starting dose of follicle-stimulating hormone (FSH).
DESIGN: Cohort study of infertile women.
SETTING: In vitro fertilisation (IVF) unit, University Hospital of Modena, Italy. POPULATION: Women aged 18-40 years (n = 346) and undergoing their first IVF cycle.
METHODS: Serum FSH and anti-Müllerian hormone (AMH) measurement. MAIN OUTCOME MEASURES: Development of a model for the prediction of ovarian response to FSH.
RESULTS: A model based on age, AMH and FSH was able to accurately predict the ovarian sensitivity and accounted for 30% of the variability of ovarian response to FSH. An FSH dosage nomogram was constructed and overall it predicts a starting FSH dose <225 IU in 55.1 and 25.9% of women younger and older than 35 years, respectively.
CONCLUSIONS: In the present study we clearly demonstrated that the daily FSH dose may be calculated on the basis of a woman's age and two markers of ovarian reserve, namely AMH and FSH, with the first two vari;s (age and AMH) being the most significant predictors. The nomogram we developed seems easily applicable for clinicians during their daily clinical practice.
© 2012 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2012 RCOG.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22805536     DOI: 10.1111/j.1471-0528.2012.03412.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  25 in total

Review 1.  Anti-Müllerian hormone as a marker of ovarian reserve: What have we learned, and what should we know?

Authors:  Akira Iwase; Tomoko Nakamura; Satoko Osuka; Sachiko Takikawa; Maki Goto; Fumitaka Kikkawa
Journal:  Reprod Med Biol       Date:  2015-11-23

2.  Severe early-onset ovarian hyperstimulation syndrome with liver dysfunction in an IVF segmentation cycle.

Authors:  Neeta Singh; Yogita Dogra; Monika Saini; Matheswari Govindarajan
Journal:  BMJ Case Rep       Date:  2020-01-26

Review 3.  Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007-2017).

Authors:  Human Fatemi; Wilma Bilger; Deborah Denis; Georg Griesinger; Antonio La Marca; Salvatore Longobardi; Mary Mahony; Xiaoyan Yin; Thomas D'Hooghe
Journal:  Reprod Biol Endocrinol       Date:  2021-05-11       Impact factor: 5.211

4.  Nomogram to predict the number of oocytes retrieved in controlled ovarian stimulation.

Authors:  Kyoung Yong Moon; Hoon Kim; Joong Yeup Lee; Jung Ryeol Lee; Byung Chul Jee; Chang Suk Suh; Ki Chul Kim; Won Don Lee; Jin Ho Lim; Seok Hyun Kim
Journal:  Clin Exp Reprod Med       Date:  2016-06-23

5.  Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count.

Authors:  Antonio La Marca; Valentina Grisendi; Simone Giulini; Cindy Argento; Alessandra Tirelli; Giulia Dondi; Enrico Papaleo; Annibale Volpe
Journal:  J Ovarian Res       Date:  2013-02-06       Impact factor: 4.234

6.  A new ovarian response prediction index (ORPI): implications for individualised controlled ovarian stimulation.

Authors:  Joao Batista A Oliveira; Ricardo L R Baruffi; Claudia G Petersen; Ana L Mauri; Adriana M Nascimento; Laura Vagnini; Juliana Ricci; Mario Cavagna; Jose G Franco
Journal:  Reprod Biol Endocrinol       Date:  2012-11-21       Impact factor: 5.211

Review 7.  Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).

Authors:  Sarah F Lensen; Jack Wilkinson; Jori A Leijdekkers; Antonio La Marca; Ben Willem J Mol; Jane Marjoribanks; Helen Torrance; Frank J Broekmans
Journal:  Cochrane Database Syst Rev       Date:  2018-02-01

8.  Association between serum anti-Müllerian hormone level and ovarian response to mild stimulation in normoovulatory women and anovulatory women with polycystic ovary syndrome.

Authors:  Ju Yeong Kim; Gwang Yi; Yeo Rang Kim; Jae Yeon Chung; Ji Hyun Ahn; You Kyoung Uhm; Byung Chul Jee; Chang Suk Suh; Seok Hyun Kim
Journal:  Clin Exp Reprod Med       Date:  2013-06-30

Review 9.  How Much Does AMH Really Vary in Normal Women?

Authors:  Antonio La Marca; Valentina Grisendi; Georg Griesinger
Journal:  Int J Endocrinol       Date:  2013-11-19       Impact factor: 3.257

10.  Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus.

Authors:  Raoul Orvieto; Christos A Venetis; Human M Fatemi; Thomas D'Hooghe; Robert Fischer; Yulia Koloda; Marcos Horton; Michael Grynberg; Salvatore Longobardi; Sandro C Esteves; Sesh K Sunkara; Yuan Li; Carlo Alviggi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-10       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.